Press "Enter" to skip to content

New patent for Novo Nordisk drug VICTOZA

0
Copyright © DrugPatentWatch. Originally published at New patent for Novo Nordisk drug VICTOZA

Annual Drug Patent Expirations for VICTOZA
Annual Drug Patent Expirations for VICTOZA

Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge.

VICTOZA drug price trends.

Drug patent litigation for VICTOZA.

This drug has two hundred and two patent family members in twenty-nine countries.

The generic ingredient in VICTOZA is liraglutide recombinant. One supplier is listed for this compound. Additional details are available on the liraglutide recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Novo Nordisk drug VICTOZA
    Do NOT follow this link or you will be banned from the site!